The DOI matches its Crossref record.
Psychopharmacology: The Fourth Generation of Progress
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Items 101–151 of 151
Distinctions between bipolar and unipolar depression
Cuellar, A. K., Johnson, S. L., & Winters, R. (2005) · Clinical Psychology Review · doi:10.1016/j.cpr.2004.12.002 · Cited by 252
Liu, C., Xie, B., Chou, C.-P., Koprowski, C., Zhou, D., Palmer, P., Sun, P., Guo, Q., Duan, L., Sun, X., et al. (2007) · Physiology & Behavior · doi:10.1016/j.physbeh.2007.05.068 · Cited by 238
Sexual activity increases dopamine transmission in the nucleus accumbens and striatum of female rats
Pfaus, J. G., Damsma, G., Wenkstern, D., & Fibiger, H. C. (1995) · Brain Research · doi:10.1016/0006-8993(95)00679-k · Cited by 236
SEX STEROID CONTROL OF MOOD, MENTAL STATE AND MEMORY
Fink, G., Sumner, B. E., McQueen, J. K., Wilson, H., & Rosie, R. (1998) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.1998.tb02151.x · Cited by 235
Tekkök, S. B., Brown, A. M., Westenbroek, R., Pellerin, L., & Ransom, B. R. (2005) · Journal of Neuroscience Research · doi:10.1002/jnr.20573 · Cited by 224
Cytokines, “depression due to a general medical condition”, and antidepressant drugs
Yirmiya, R., Weidenfeld, J., Pollak, Y., Morag, M., Morag, A., Avitsur, R., Barak, O., Reichenberg, A., Cohen, E., Shavit, Y., et al. (1999) · Advances in Experimental Medicine and Biology · doi:10.1007/978-0-585-37970-8_16 · Cited by 208
Atypical Antipsychotics Part I: Pharmacology, Pharmacokinetics, and Efficacy
Markowitz, J. S., Brown, C. S., & Moore, T. R. (1999) · Annals of Pharmacotherapy · doi:10.1345/aph.17215 · Cited by 208
Slotkin, T. A. (2008) · Neurotoxicology and Teratology · doi:10.1016/j.ntt.2007.09.002 · Cited by 206
Kunugi, H., Ida, I., Owashi, T., Kimura, M., Inoue, Y., Nakagawa, S., Yabana, T., Urushibara, T., Kanai, R., Aihara, M., et al. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300868 · Cited by 200
Kunugi, H., Hori, H., Adachi, N., & Numakawa, T. (2010) · Psychiatry and Clinical Neurosciences · doi:10.1111/j.1440-1819.2010.02135.x · Cited by 200
Oxytocin Control of Maternal Behavior Regulation by Sex Steroids and Offspring Stimulia
PEDERSEN, C. A. (1997) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1997.tb51916.x · Cited by 172
Antidepressant-like effect of harmane and other β-carbolines in the mouse forced swim test
Farzin, D., & Mansouri, N. (2006) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2005.08.005 · Cited by 171
Schoedl, A. F., Costa, M. C. P., Mari, J. J., Mello, M. F., Tyrka, A. R., Carpenter, L. L., & Price, L. H. (2010) · Journal of Child Sexual Abuse · doi:10.1080/10538711003615038 · Cited by 164
Psychoneuroimmunology of depression: clinical implications
Irwin, M. (2002) · Brain, Behavior, and Immunity · doi:10.1006/brbi.2001.0654 · Cited by 160
Markus, C. R., Jonkman, L. M., Lammers, J. H., Deutz, N. E., Messer, M. H., & Rigtering, N. (2005) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/81.5.1026 · Cited by 157
Luo, D. D., An, S. C., & Zhang, X. (2008) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2008.05.010 · Cited by 155
Saveanu, R., Etkin, A., Duchemin, A.-M., Goldstein-Piekarski, A., Gyurak, A., Debattista, C., Schatzberg, A. F., Sood, S., Day, C. V. A., Palmer, D. M., et al. (2015) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2014.12.018 · Cited by 151
Caffeine Withdrawal: A Parametric Analysis of Caffeine Dosing Conditions
Evans, S. M., & Griffiths, R. R. (1999) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38135-2 · Cited by 145
Elevated Concentrations of CRF in the Locus Coeruleus of Depressed Subjects
Bissette, G., Klimek, V., Pan, J., Stockmeier, C., & Ordway, G. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300191 · Cited by 136
The age-dependent effects of selective serotonin reuptake inhibitors in humans and rodents: a review
Olivier, J. D. A., Blom, T., Arentsen, T., & Homberg, J. R. (2011) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.09.013 · Cited by 131
Riba, J., Anderer, P., Morte, A., Urbano, G., Jané, F., Saletu, B., & Barbanoj, M. J. (2002) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.2002.01609.x · Cited by 125
Booij, L., Van der Does, A. J. W., Haffmans, P. M. J., Riedel, W. J., Fekkes, D., & Blom, M. J. B. (2005) · Journal of Psychopharmacology · doi:10.1177/0269881105051538 · Cited by 105
24-h Monitoring of plasma norepinephrine, MHPG, cortisol, growth hormone and prolactin in depression
Koenigsberg, H. W., Teicher, M. H., Mitropoulou, V., Navalta, C., New, A. S., Trestman, R., & Siever, L. J. (2004) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2004.03.006 · Cited by 104
Helton, D. R., Tizzano, J. P., Monn, J. A., Schoepp, D. D., & Kallman, M. J. (1997) · Neuropharmacology · doi:10.1016/s0028-3908(97)00170-6 · Cited by 103
Londborg, P. D., Smith, W. T., Glaudin, V., & Painter, J. R. (2000) · Journal of Affective Disorders · doi:10.1016/s0165-0327(99)00195-0 · Cited by 100
Roiser, J. P., McLean, A., Ogilvie, A. D., Blackwell, A. D., Bamber, D. J., Goodyer, I., Jones, P. B., & Sahakian, B. J. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300659 · Cited by 96
Coplan, J. D., Gopinath, S., Abdallah, C. G., & Berry, B. R. (2014) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2014.00189 · Cited by 90
Serotonin: modulator of a drive to withdraw.
Tops, M., Russo, S., Boksem, M. A. S., & Tucker, D. M. (2009) · Brain and Cognition · doi:10.1016/j.bandc.2009.03.009 · Cited by 86
Bari, A., & Aston-Jones, G. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.07.020 · Cited by 85
Andersen, S. L. (2002) · Behavioural Brain Research · doi:10.1016/s0166-4328(01)00417-x · Cited by 80
Jackson, C. R., Chaurasia, S. S., Hwang, C. K., & Michael Iuvone, P. (2011) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2011.07734.x · Cited by 76
Herrera-Guzmán, I., Gudayol-Ferré, E., Lira-Mandujano, J., Herrera-Abarca, J., Herrera-Guzmán, D., Montoya-Pérez, K., & Guardia-Olmos, J. (2008) · Psychiatry Research · doi:10.1016/j.psychres.2007.04.012 · Cited by 78
Bufotenine: Toward an understanding of possible psychoactive mechanisms
McBride, M. C. (2000) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2000.10400456 · Cited by 74
Psychostimulant and other effects of caffeine in 9- to 11-year-old children
Heatherley, S. V., Hancock, K. M. F., & Rogers, P. J. (2006) · Journal of Child Psychology and Psychiatry · doi:10.1111/j.1469-7610.2005.01457.x · Cited by 74
Preclinical Behavioral Models for Predicting Antipsychotic Activity
Castagné, V., Moser, P. C., & Porsolt, R. D. (2009) · Advances in Pharmacology · doi:10.1016/s1054-3589(08)57010-4 · Cited by 64
Higher Baseline Interleukin-1β and TNF-α Hamper Antidepressant Response in Major Depressive Disorder
Benedetti, F., Poletti, S., Vai, B., Mazza, M. G., Lorenzi, C., Brioschi, S., Aggio, V., Branchi, I., Colombo, C., Furlan, R., et al. (2021) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2020.11.009 · Cited by 62
(1997) · American Journal of Psychiatry · doi:10.1176/ajp.154.2.211 · Cited by 58
Tafet, G. E., Feder, D. J., Abulafia, D. P., & Roffman, S. S. (2005) · Cognitive, Affective, & Behavioral Neuroscience · doi:10.3758/cabn.5.1.37 · Cited by 53
Rebec, G. V. (1998) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.1998.tb03614.x · Cited by 51
Assessing the validity of current mouse genetic models of obsessive-compulsive disorder
Wang, L., Simpson, H. B., & Dulawa, S. C. (2009) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e32832a80ad · Cited by 50
Genetic approaches for understanding the role of serotonin receptors in mood and behavior
Donaldson, Z. R., Nautiyal, K. M., Ahmari, S. E., & Hen, R. (2013) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2013.01.011 · Cited by 42
Chronotherapeutics (light and wake therapy) as a class of interventions for affective disorders
(2012) · Handbook of Clinical Neurology · doi:10.1016/b978-0-444-52002-9.00042-5 · Cited by 42
Lee, M. T., Mpavaenda, D. N., & Fineberg, N. A. (2019) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2019.00079 · Cited by 40
Lewis, A. S., & Picciotto, M. R. (2013) · Psychopharmacology · doi:10.1007/s00213-013-3126-5 · Cited by 38
Affective Biases in Humans and Animals
Robinson, E. S. J., & Roiser, J. P. (2015) · Current Topics in Behavioral Neurosciences · doi:10.1007/7854_2015_5011 · Cited by 37
Translational Assessments of Reward and Anhedonia: A Tribute to Athina Markou
Der-Avakian, A., & Pizzagalli, D. A. (2018) · Biological Psychiatry · doi:10.1016/j.biopsych.2018.02.008 · Cited by 36
Alzheimer’s Disease: The Alternative Serotonergic Hypothesis of Cognitive Decline
Vakalopoulos, C. (2017) · Journal of Alzheimer's Disease · doi:10.3233/jad-170364 · Cited by 34
Srisurapanont, M., Jarusuraisin, N., & Jittiwutikan, J. (1999) · Australian & New Zealand Journal of Psychiatry · doi:10.1046/j.1440-1614.1999.00518.x · Cited by 34
Loizzo, S., Campana, G., Vella, S., Fortuna, A., Galietta, G., Guarino, I., Costa, L., Capasso, A., Renzi, P., Frajese, G. V., et al. (2010) · Peptides · doi:10.1016/j.peptides.2010.08.001 · Cited by 24
Neuroendocrine Regulation of Male Sexual Behavior
Hull, E. M., & Dominguez, J. M. (2019) · Comprehensive Physiology · doi:10.1002/cphy.c180018 · Cited by 21
A unifying hypothesis of alzheimer’s disease: III—Risk factors
Heininger, K. (2000) · Human Psychopharmacology: Clinical and Experimental · doi:10.1002/(sici)1099-1077(200001)15:1<1::aid-hup153>3.0.co;2-1
Metadata
- Authors
- Green, A. I.
- Venue
- Psychiatric Services
- Published
- 1996-03
- Volume
- 47
- Issue
- 3
- Pages
- 312-313
- ISSN
- 0022-1597 (ISSN-L)
- 1075-2730
- 1557-9700
- OpenAlex
- W2047313629
- Cited by
- 1,145
- References
- 0
- FWCI
- 124.92
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.